Mumps Disease

BASICS

DESCRIPTION
Acute generalized paramyxovirus infection usually presenting with unilateral or bilateral parotitis. Epidemics late winter and spring with transmission by respiratory secretions. Incubation is approximately 14 to 24 days.
  • System(s) affected: Reproductive, Hemic/Lymphatic/Immunologic, Skin/Exocrine
  • Genetics: N/A
  • Incidence/Prevalence in USA:
    • 0.29/100,000 (725 per year)
    • 0.0064/100,000
    • 90% of adults are seropositive even without history
  • Predominant age: 85% occur before age 15 years, but more severe in adults
  • Predominant sex: Male = Female
SIGNS AND SYMPTOMS
  • Parotid pain and swelling in one or both glands
  • Rare prodrome of fever, neck muscle ache, malaise
  • Initial parotid swelling just behind jaw
  • Swelling peaks in 1–3 days, lasts 3–7 days
  • Obscures angle of mandible
  • Elevates earlobe
  • Redness at opening of Stensen's duct
  • Sour foods cause pain in the parotid gland region
  • Moderate fever, usually not above 104°F (40.0°C). High fever is frequently associated with complications.
  • Meningeal signs in 15%, encephalitis in 0.5%
  • Rarely arthritis, orchitis, thyroiditis, mastitis, pancreatitis
  • Rare maculopapular erythematous rash
  • Up to 50% of cases may be asymptomatic
  • Swelling in the sternal area, rare, but pathognomonic of mumps
CAUSES
  • Mumps paramyxovirus
  • Other viruses, such as Coxsackie (rare)
RISK FACTORS
  • Urban epidemics, non-vaccinated population
  • Usual communicable period is 24 hours before to 72 hours after onset of parotitis
  • Incubation period usually 18 days

DIAGNOSIS

LABORATORY
  • Viral isolation from throat washings, urine, blood, or spinal fluid
  • Serum amylase elevated
  • Rise in paired antibodies: Anti-"S" antibodies peak early and may be seen at the time of presentation
  • Cerebrospinal fluid (CSF) - leukocytosis
  • Leukopenia

Drugs that may alter lab results: N/A
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS
Periductal edema and lymphocytic infiltration
SPECIAL TESTS
Rarely necessary, an easier salivary test for IgM is pending
IMAGING
Useful to differentiate mumps orchitis from testicular torsion
DIAGNOSTIC PROCEDURES
N/A

TREATMENT

APPROPRIATE HEALTH CARE
  • Outpatient, if no complications
  • High fever and testicular pain - may hospitalize for steroids or interferon
GENERAL MEASURES
  • Supportive and symptomatic care
  • For patients with orchitis, ice packs to scrotum can help relieve pain
  • Scrotal support with adhesive bridge while recumbent and/or athletic supporter while ambulatory
  • Use IV fluids if severe nausea or vomiting accompanies pancreatitis
SURGICAL MEASURES

N/A

ACTIVITY

Mumps orchitis - bedrest and local supportive clothing, such as wearing 2 pairs of briefs, or adhesive-tape bridge

DIET

Liquids if cannot chew

PATIENT EDUCATION
  • Must be out of school until no longer contagious – about 9 days after onset of pain
  • Orchitis is common in older children but rarely results in sterility
  • Immunization of family may protect against later exposures but not the present one

FOLLOW UP

PREVENTION/AVOIDANCE
  • 2 doses of live mumps vaccine recommended for active immunization: at 15 months and at entry to middle school (postexposure vaccination does not protect from recent exposure)
  • Isolate hospitalized patients until 9 days past onset
POSSIBLE COMPLICATIONS
  • May precede, accompany, or follow salivary gland involvement and may occur (rarely) without primary involvement of the parotid gland
  • Meningitis or encephalitis may present 10 days after first symptoms of illness. Aseptic meningitis is typically mild, but meningo-encephalitis may lead to seizures, paralysis, hydrocephalus, or, in 2% of cases, death
  • Cerebrospinal fluid (CSF) pleocytosis, usually lymphocytes, found in 65% of cases with parotitis
  • Orchitis common (30%) in postpubertal boys; starts within 8 days after parotitis; fever, swollen testis of 4-day duration; fertility impaired in 13% but absolute sterility is rare
  • Oophoritis in 7% of postpubertal females, no decreased fertility
  • Pancreatitis, usually mild
  • Nephritis, thyroiditis, or arthralgias are rare
  • Myocarditis – usually mild, but may depress ST segment; may be linked to endocardial fibroelastosis
  • Deafness – 1/15,000 unilateral nerve deafness; may not be permanent
  • Inflammation about the eye (rare)
  • Dacryoadenitis, optic neuritis
EXPECTED COURSE AND PROGNOSIS
  • Complete recovery is usual, immunity is permanent
  • Sensorineural hearing loss in 4% of adults - transient
  • Rare recurrence after 2 weeks may be recurrent non-epidemic parotitis

MISCELLANEOUS

ASSOCIATED CONDITIONS

N/A

AGE-RELATED FACTORS

Pediatric:

  • In adolescents - orchitis more common
  • Most cases of acute epidemic mumps occur in children aged 5 to 15. Unusual in children less than 2 years. Most infants less than 1 year are immune
  • Less likely to develop complications

Geriatric: Most are immune
Others: Most complications occur in post-pubertal group

PREGNANCY
  • No proven complications of vaccine, but theoretically should not vaccinate in pregnancy
  • Disease may increase rate of spontaneous abortion in first trimester
OTHER NOTES

A portion of people infected with mumps virus have no parotid swelling and a clinically inapparent infection

ABBREVIATIONS

N/A

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.